Coronavirus (COVID-19) Treatment

COVID-19 Community Based Treatments

Content Summary

Information on the local Derbyshire CMDU pathway

COVID-19 Medicine Delivery Unit (CMDU)

Referral can be made to the local CMDU service via the Electronic Referral Service, or via the direct number used for Red Hub referrals 0300 1000 432 or by emailing UCD.admin@nhs.net.

Please include:

Patient details
NHS number
Underlying qualifying clinical condition
Date of symptom onset
Date of PCR
Where possible, also include a copy of the PCR pathology report

Out of Area information can be found here

National Guidance	Content summary
COVID-19: information and advice for health and care professionals	GOV.UK - Background information and advice on coronavirus (COVID-19) for health and care professionals
Higher-risk patients eligible for COVID-19 treatments: independent advisory group report (March 2023)	Update to the independent advisory group report that identifies which patient groups are at highest risk of serious illness from COVID-19 and would benefit from new COVID-19 treatments.
Casirivimab plus imdevimab, nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19	Evidence-based recommendations on casirivimab plus imdevimab (Ronapreve), nirmatrelvir plus ritonavir (Paxlovid), sotrovimab (Xevudy) and tocilizumab (RoActemra) for treating COVID-19.
COVID-19 rapid guideline: Managing COVID-19	This guideline covers the management of COVID-19 for babies, children, young people and adults in all care settings. It brings together our existing recommendations on managing COVID-19, and new recommendations on therapeutics, so that healthcare staff and those planning and delivering services can find and use them more easily.